Klaus Pels

516 total citations
19 papers, 320 citations indexed

About

Klaus Pels is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Klaus Pels has authored 19 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 10 papers in Cardiology and Cardiovascular Medicine and 6 papers in Molecular Biology. Recurrent topics in Klaus Pels's work include Coronary Interventions and Diagnostics (12 papers), Acute Myocardial Infarction Research (8 papers) and Angiogenesis and VEGF in Cancer (6 papers). Klaus Pels is often cited by papers focused on Coronary Interventions and Diagnostics (12 papers), Acute Myocardial Infarction Research (8 papers) and Angiogenesis and VEGF in Cancer (6 papers). Klaus Pels collaborates with scholars based in Germany, Canada and United States. Klaus Pels's co-authors include Marino Labinaz, Edward R. O’Brien, Ursula Rauch, Petra Goldin-Lang, Heinz‐Peter Schultheiss, Silvio Antoniak, Peter Rosenthal, Cyrla Hoffert, Peter Schwimmbeck and Carolin Deiner and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Klaus Pels

19 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klaus Pels Germany 11 126 119 104 47 43 19 320
P. M. van der Zee Netherlands 8 54 0.4× 169 1.4× 120 1.2× 22 0.5× 60 1.4× 14 336
Nawsad Saleh Sweden 10 166 1.3× 273 2.3× 102 1.0× 29 0.6× 114 2.7× 19 449
K. Tan Canada 8 98 0.8× 78 0.7× 57 0.5× 38 0.8× 72 1.7× 23 343
Ted W. Love United States 7 125 1.0× 199 1.7× 38 0.4× 61 1.3× 69 1.6× 14 339
Xuedong Sun China 13 130 1.0× 24 0.2× 84 0.8× 49 1.0× 37 0.9× 50 476
Artur Oliver Spain 8 109 0.9× 75 0.6× 59 0.6× 9 0.2× 17 0.4× 11 381
Garth Beinart United States 6 162 1.3× 26 0.2× 151 1.5× 64 1.4× 10 0.2× 9 510
Chikaho KITADA Japan 4 63 0.5× 94 0.8× 105 1.0× 17 0.4× 12 0.3× 5 349
Elizabeth Levin United States 7 180 1.4× 98 0.8× 36 0.3× 15 0.3× 12 0.3× 9 335
Laura Cavallotti Italy 12 133 1.1× 277 2.3× 75 0.7× 19 0.4× 40 0.9× 26 430

Countries citing papers authored by Klaus Pels

Since Specialization
Citations

This map shows the geographic impact of Klaus Pels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Pels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Pels more than expected).

Fields of papers citing papers by Klaus Pels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Pels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Pels. The network helps show where Klaus Pels may publish in the future.

Co-authorship network of co-authors of Klaus Pels

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Pels. A scholar is included among the top collaborators of Klaus Pels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Pels. Klaus Pels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Rauch, Ursula, Petra Goldin-Lang, Andreas Eisenreich, et al.. (2010). Prolonged clopidogrel application reduces tissue factor expression after percutaneous coronary intervention in the porcine model. Cardiovascular revascularization medicine. 12(1). 47–55. 3 indexed citations
2.
Pels, Klaus, Peter Schwimmbeck, Peter Rosenthal, et al.. (2009). Long‐term clopidogrel administration following severe coronary injury reduces proliferation and inflammation via inhibition of nuclear factor‐kappaB and activator protein 1 activation in pigs. European Journal of Clinical Investigation. 39(3). 174–182. 9 indexed citations
3.
Deiner, Carolin, et al.. (2009). Complex porcine model of atherosclerosis: Induction of early coronary lesions after long-term hyperlipidemia without sustained hyperglycemia. Canadian Journal of Cardiology. 25(4). e109–e114. 9 indexed citations
4.
Pels, Klaus, Joachim Schröder, Bernhard Witzenbichler, et al.. (2008). Prehospital versus periprocedural abciximab in ST -elevation myocardial infarction treated by percutaneous coronary intervention. European Journal of Emergency Medicine. 15(6). 324–329. 12 indexed citations
5.
Geller, J. Christoph, Ulrich Keil, Johannes Bernarding, et al.. (2007). Achievement of guideline-defined treatment goals in primary care: the German Coronary Risk Management (CoRiMa) study. European Heart Journal. 28(24). 3051–3058. 32 indexed citations
6.
Rauch, Ursula, Petra Goldin-Lang, Carolin Deiner, et al.. (2007). Prolonged application of clopidogrel reduces inflammation after percutaneous coronary intervention in the porcine model. Cardiovascular revascularization medicine. 8(3). 183–188. 13 indexed citations
7.
Deiner, Carolin, Christoph Loddenkemper, Ursula Rauch, et al.. (2007). Mechanisms of late lumen loss after antiproliferative percutaneous coronary intervention using beta-irradiation in a porcine model of restenosis. Cardiovascular revascularization medicine. 8(2). 94–98. 3 indexed citations
8.
Goldin-Lang, Petra, Silvio Antoniak, Peter Rosenthal, et al.. (2007). Ionizing radiation induces upregulation of cellular procoagulability and tissue factor expression in human peripheral blood mononuclear cells. Thrombosis Research. 120(6). 857–864. 23 indexed citations
9.
Goldin-Lang, Petra, Klaus Pels, Silvio Antoniak, et al.. (2007). Effect of ionizing radiation on cellular procoagulability and co-ordinated gene alterations. Haematologica. 92(8). 1091–1098. 15 indexed citations
10.
Antoniak, Silvio, Petra Goldin-Lang, Klaus Pels, et al.. (2006). Antioxidative treatment inhibits the release of thrombogenic tissue factor from irradiation- and cytokine-induced endothelial cells. Cardiovascular Research. 73(4). 806–812. 69 indexed citations
11.
Deiner, Carolin, Peter Schwimmbeck, Christoph Loddenkemper, et al.. (2006). Adventitial VEGF165 gene transfer prevents lumen loss through induction of positive arterial remodeling after PTCA in porcine coronary arteries. Atherosclerosis. 189(1). 123–132. 21 indexed citations
13.
Pels, Klaus. (2003). Effect of adventitial VEGF165 gene transfer on vascular thickening after coronary artery balloon injury. Cardiovascular Research. 60(3). 664–672. 17 indexed citations
14.
Labinaz, Marino, et al.. (2000). Infusion of an antialpha4 integrin antibody is associated with less neoadventitial formation after balloon injury of porcine coronary arteries.. PubMed. 16(2). 187–96. 8 indexed citations
15.
Pels, Klaus, Marino Labinaz, Cyrla Hoffert, & Edward R. O’Brien. (1999). Adventitial Angiogenesis Early After Coronary Angioplasty. Arteriosclerosis Thrombosis and Vascular Biology. 19(2). 229–238. 41 indexed citations
16.
Pels, Klaus, Marino Labinaz, & Edward R. O’Brien. (1997). Arterial Wall Neovascularization:Potential Role in Atherosclerosis and Restenosis. Circulation. 61(11). 893–904. 1 indexed citations
17.
Heins, Michael, F. C. Schoebel, Klaus Pels, et al.. (1997). Activation of the Fibrinolytic System in Patients with Coronary Artery Disease and Hyperfibrinogenemia. Thrombosis and Haemostasis. 77(5). 970–974. 10 indexed citations
18.
Pels, Klaus, Marino Labinaz, & Edward R. O’Brien. (1997). Arterial Wall Neovascularization. Japanese Circulation Journal. 61(11). 893–904. 19 indexed citations
19.
Schoebel, F. C., Matthias Leschke, Klaus Pels, et al.. (1995). Chronic-intermittent urokinase therapy in refractory angina pectoris. Fibrinolysis and Proteolysis. 9. 121–125. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026